Delcath enters launch and training agreements with IEO

November 2011
Medical Device Daily;11/28/2011, Vol. 15 Issue 226, p2
The article reports that Delcath Systems of New York has entered into an initial launch and training agreement with the European Institute of Oncology (Instituto Europeo de Oncologia, or IEO), a European cancer treatment and research center in Milan, Italy, for the Delcath Hepatic Chemostat Delivery system.


Related Articles

  • Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum].  // Breast Cancer: Targets & Therapy;Mar2018, Vol. 11, p51 

    No abstract available.

  • Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002. Botteri, E.; Iodice, S.; Maisonneuve, P.; Alfieri, M.; Burzoni, N.; Manghi, L.; Martinetti, M.; Montanari, B.; Albertazzi, E.; Bazolli, B.; Rotmensz, N. // Ecancermedicalscience;2009, Vol. 3, p1 

    Introduction: An institutional and centralized hospital-based tumour registry (TR) is the ideal supporting tool for the organization and management of clinical data in a comprehensive cancer centre. The purpose of this paper is to describe the development of the TR at the European Institute of...

  • European Institute of Oncology inaugurated in Milan. Vanchieri, Cori // JNCI: Journal of the National Cancer Institute;6/1/94, Vol. 86 Issue 11, p827 

    Reports on the inauguration of the European Institute of Oncology in Milan, Italy. Staff; Agreements with European academic institutes regarding career issues.

  • Oncology Nursing Minimum Data Set (ONMDS): can we hypothesize a set of prevalent Nursing Sensitive Outcomes (NSO) in cancer patients? Milani, A.; Mauri, S.; Gandini, S.; Magon, G. // Ecancermedicalscience;2013, Vol. 7 Issue 334-360, p1 

    Background: The nursing minimum data set (NMDS) was created in 1977 in the United States to collect uniform standardised data that could be comparable among different nursing areas or patients. So far, in the literature, an NMDS in an oncology setting has not yet been described. Considering an...

  • Treatment - Radiotherapy.  // Current Medical Literature: Breast Cancer;2010, Vol. 22 Issue 4, p147 

    The article discusses two studies on intraoperative radiotherapy. The first study, conducted by Vaidya et al., presents the results from a collaborative international, randomized, clinical trial, which compared targeted intraoperative radiotherapy against whole breast radiotherapy for breast...

  • Correlation between administered treatment and patient's living will. Andreoni, B.; Goldhirsch, A.; Orecchia, R.; Venturino, M.; Spirito, R.; Tadini, L.; Corbellini, C.; Bertani, E.; Veronesi, U. // Ecancermedicalscience;2009, Vol. 3, p1 

    Respecting the wishes of an adequately informed patient should be a priority in any health structure. A patient with advanced or terminal cancer should be allowed to express their will during the most important phases of their illness. Unfortunately, this is seldom the case, and in general...

  • The role of [18F]FDG-PET/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy. Lazzari, Roberta; Cecconi, Agnese; Jereczek-Fossa, Barbara A.; Travaini, Laura Lavinia; Dell' Acqua, Veronica; Cattani, Federica; Rizzo, Stefania; Fodor, Cristiana; Landoni, Fabio; Orecchia, Roberto // Ecancermedicalscience;2014, Vol. 8 Issue 381-412, p1 

    Rationale: to evaluate the role of 18F-fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) integrated with computer tomography (CT) scan [18F]FDG-PET/CT in the staging and target volume definition in Intensity Modulated RapidarcTM Delivery (RA-IMRT) in cervical cancer. Methods: From...

  • Twenty years of activity at the European Institute of Oncology, Milan, Italy. Cairns, Linda // Ecancermedicalscience;2014, Vol. 8 Issue 474-494, p1 

    The author reflects on the success of the European Institute of Oncology (EIO), an international multidisciplinary cancer centre in Milan, Italy. She discusses the services of EIO including its palliative care and radiotherapy services. She also mentions the opening of the first integrated...

  • Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology. Biffi, R.; Orsi, F.; Zampino, M. G.; Chiappa, A.; Fazio, N.; De Braud, F.; Bonomo, G.; Monfardini, L.; Vigna, P. D.; Luca, F.; Bodei, L.; Bartolomei, M.; Catalano, G.; Leonardi, M. C.; Ferrari, M.; Andreoni, B.; Goldhirsch, A.; Paganelli, G.; Orecchia, R. // Ecancermedicalscience;2008, Vol. 2, p1 

    Background: An institutional task force on upper gastrointestinal tumours is active at the European Institute of Oncology (EIO). Members decided to collate the institutional guidelines on management of liver tumours (primary and metastatic) into a document. This article is aimed at presenting...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics